Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600

Thomas E Nordahl, Natalia Kusubov, Cameron S Carter, Shahriar Salamat, Anne M. Cummings, Linda O'Shora-Celaya, Jamie Eberling, Lynn Robertson, Ronald H. Huesman, William Jagust, Thomas F. Budinger

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Regional cerebral glucose metabolic rates (rCMXglc)) were compared in 18 unmedicated outpatients with schizophrenia and 11 normal controls using high resolution positron emission tomography (PET) and the tracer [F-18]-2-fluoro-2D-deoxyglucose (FDG). From previous work we expected to see abnormal hippocampal rCMRglc in the patients, but MO striatal abnormalities. Trial-by-trial Stroop cognitive task, which has been shown to activate the anterior cingulate, was performed within a day of the PET study. As our patients performed abnormally on the Stroop we tested for a correlation between the anterior cingulate rCMRglc and Stroop performance. We found no whole slice cortical average glucose metabolic abnormalities. As predicted we found abnormally decreased left hippocampal rCMRglc in the patients. No striatal or cingulate rCMRglc abnormalities were noted in patients, but they demonstrated a highly positive correlation between anterior and cingulate rCMRglc and Stroop facilitation. Patients with higher Stroop interference had more prominent hippocampal metabolic decreases. These localized temporal lobe abnormalities could account for some of the patient's positive symptoms and are consistent with recent findings in the literature.

Original languageEnglish (US)
Pages (from-to)541-554
Number of pages14
JournalNeuropsychopharmacology
Volume15
Issue number6
DOIs
StatePublished - Dec 1996

Fingerprint

Temporal Lobe
Positron-Emission Tomography
Schizophrenia
Outpatients
Gyrus Cinguli
Corpus Striatum
Glucose
Deoxyglucose

ASJC Scopus subject areas

  • Pharmacology

Cite this

Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. / Nordahl, Thomas E; Kusubov, Natalia; Carter, Cameron S; Salamat, Shahriar; Cummings, Anne M.; O'Shora-Celaya, Linda; Eberling, Jamie; Robertson, Lynn; Huesman, Ronald H.; Jagust, William; Budinger, Thomas F.

In: Neuropsychopharmacology, Vol. 15, No. 6, 12.1996, p. 541-554.

Research output: Contribution to journalArticle

Nordahl, TE, Kusubov, N, Carter, CS, Salamat, S, Cummings, AM, O'Shora-Celaya, L, Eberling, J, Robertson, L, Huesman, RH, Jagust, W & Budinger, TF 1996, 'Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600', Neuropsychopharmacology, vol. 15, no. 6, pp. 541-554. https://doi.org/10.1016/S0893-133X(96)00098-X
Nordahl, Thomas E ; Kusubov, Natalia ; Carter, Cameron S ; Salamat, Shahriar ; Cummings, Anne M. ; O'Shora-Celaya, Linda ; Eberling, Jamie ; Robertson, Lynn ; Huesman, Ronald H. ; Jagust, William ; Budinger, Thomas F. / Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. In: Neuropsychopharmacology. 1996 ; Vol. 15, No. 6. pp. 541-554.
@article{58df0ce090414292b3e666984e95ec90,
title = "Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600",
abstract = "Regional cerebral glucose metabolic rates (rCMXglc)) were compared in 18 unmedicated outpatients with schizophrenia and 11 normal controls using high resolution positron emission tomography (PET) and the tracer [F-18]-2-fluoro-2D-deoxyglucose (FDG). From previous work we expected to see abnormal hippocampal rCMRglc in the patients, but MO striatal abnormalities. Trial-by-trial Stroop cognitive task, which has been shown to activate the anterior cingulate, was performed within a day of the PET study. As our patients performed abnormally on the Stroop we tested for a correlation between the anterior cingulate rCMRglc and Stroop performance. We found no whole slice cortical average glucose metabolic abnormalities. As predicted we found abnormally decreased left hippocampal rCMRglc in the patients. No striatal or cingulate rCMRglc abnormalities were noted in patients, but they demonstrated a highly positive correlation between anterior and cingulate rCMRglc and Stroop facilitation. Patients with higher Stroop interference had more prominent hippocampal metabolic decreases. These localized temporal lobe abnormalities could account for some of the patient's positive symptoms and are consistent with recent findings in the literature.",
author = "Nordahl, {Thomas E} and Natalia Kusubov and Carter, {Cameron S} and Shahriar Salamat and Cummings, {Anne M.} and Linda O'Shora-Celaya and Jamie Eberling and Lynn Robertson and Huesman, {Ronald H.} and William Jagust and Budinger, {Thomas F.}",
year = "1996",
month = "12",
doi = "10.1016/S0893-133X(96)00098-X",
language = "English (US)",
volume = "15",
pages = "541--554",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600

AU - Nordahl, Thomas E

AU - Kusubov, Natalia

AU - Carter, Cameron S

AU - Salamat, Shahriar

AU - Cummings, Anne M.

AU - O'Shora-Celaya, Linda

AU - Eberling, Jamie

AU - Robertson, Lynn

AU - Huesman, Ronald H.

AU - Jagust, William

AU - Budinger, Thomas F.

PY - 1996/12

Y1 - 1996/12

N2 - Regional cerebral glucose metabolic rates (rCMXglc)) were compared in 18 unmedicated outpatients with schizophrenia and 11 normal controls using high resolution positron emission tomography (PET) and the tracer [F-18]-2-fluoro-2D-deoxyglucose (FDG). From previous work we expected to see abnormal hippocampal rCMRglc in the patients, but MO striatal abnormalities. Trial-by-trial Stroop cognitive task, which has been shown to activate the anterior cingulate, was performed within a day of the PET study. As our patients performed abnormally on the Stroop we tested for a correlation between the anterior cingulate rCMRglc and Stroop performance. We found no whole slice cortical average glucose metabolic abnormalities. As predicted we found abnormally decreased left hippocampal rCMRglc in the patients. No striatal or cingulate rCMRglc abnormalities were noted in patients, but they demonstrated a highly positive correlation between anterior and cingulate rCMRglc and Stroop facilitation. Patients with higher Stroop interference had more prominent hippocampal metabolic decreases. These localized temporal lobe abnormalities could account for some of the patient's positive symptoms and are consistent with recent findings in the literature.

AB - Regional cerebral glucose metabolic rates (rCMXglc)) were compared in 18 unmedicated outpatients with schizophrenia and 11 normal controls using high resolution positron emission tomography (PET) and the tracer [F-18]-2-fluoro-2D-deoxyglucose (FDG). From previous work we expected to see abnormal hippocampal rCMRglc in the patients, but MO striatal abnormalities. Trial-by-trial Stroop cognitive task, which has been shown to activate the anterior cingulate, was performed within a day of the PET study. As our patients performed abnormally on the Stroop we tested for a correlation between the anterior cingulate rCMRglc and Stroop performance. We found no whole slice cortical average glucose metabolic abnormalities. As predicted we found abnormally decreased left hippocampal rCMRglc in the patients. No striatal or cingulate rCMRglc abnormalities were noted in patients, but they demonstrated a highly positive correlation between anterior and cingulate rCMRglc and Stroop facilitation. Patients with higher Stroop interference had more prominent hippocampal metabolic decreases. These localized temporal lobe abnormalities could account for some of the patient's positive symptoms and are consistent with recent findings in the literature.

UR - http://www.scopus.com/inward/record.url?scp=0030561038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030561038&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(96)00098-X

DO - 10.1016/S0893-133X(96)00098-X

M3 - Article

C2 - 8946428

AN - SCOPUS:0030561038

VL - 15

SP - 541

EP - 554

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 6

ER -